Early Phase II RCT of Tramates (Coriolus) versicolor (1500 mg TID PO) in Women with Stage (I/II/III) ER/PR Negative Breast Cancer
The main outcome was to study the mean rate of change in Natural Killer Cell Activity in patients who have undergone conventional breast cancer protocol: chemotherapy followed by radiotherapy in which there is a subseqent decrease in Natural Killer Cell Activity. The study was funded by CTRF and was halted as naturopaths were unable to recruit patients for the study. The attachments outline the rational for the study along with timeline.
Download the CTRF Clinical Study, click here.
Download the CTRF Clinical Timeline, click here.